Calidi Biotherapeutics, Inc. Entity Listing, Par Value Per Share
Calidi Biotherapeutics, Inc. (CLDI) reported Entity Listing, Par Value Per Share of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-08-13
- Calidi Biotherapeutics, Inc. entity listing, par value per share for the quarter ending 2026-03-31 was $0.00, a 0.00% change year-over-year.
- Calidi Biotherapeutics, Inc. entity listing, par value per share for the quarter ending 2025-03-31 was $0.00.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |